Zessly®
ACTIVE PRINCIPLE:
Infliximab
INDICATION:
Ankylosing spondylitis
Rheumatoid arthritis
Ulcerative colitis
Psoriasic arthritis
Crohn's disease
Psoriasis
DATE:
16/07/2018
STATUS:
Authorized
ACTIVE PRINCIPLE:
Infliximab
INDICATION:
Ankylosing spondylitis
Rheumatoid arthritis
Ulcerative colitis
Psoriasic arthritis
Crohn's disease
Psoriasis
DATE:
16/07/2018
STATUS:
Authorized